510(k) K201181

EnSite Velocity Cardiac Mapping System, EnSite Precision Cardiac Mapping System by ABBOTT MEDICAL — Product Code DQK

K201181 is an FDA 510(k) premarket notification submitted by ABBOTT MEDICAL for the device "EnSite Velocity Cardiac Mapping System, EnSite Precision Cardiac Mapping System". The FDA issued a decision of Substantially Equivalent on Jun 26, 2020. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. ABBOTT MEDICAL has 59 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 26, 2020
Date Received
Apr 30, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Computer, Diagnostic, Programmable
Device Class
Class II
Regulation Number
870.1425
Review Panel
CV
Submission Type
510(k)